Log In
Print this Print this

Colorectal Cancer DSA microarray-based signature

  Manage Alerts
Collapse Summary General Information
Company Almac Group Ltd.
Description634-transcript genetic signature derived from formalin-fixed paraffin-embedded (FFPE) tumor samples
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsPredict stage II colon cancer recurrence
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today